Get the Stockscreener App
1.86
0.54%
0.01
Alector Inc stock is traded at $1.86, with a volume of 3.85M.
It is up +0.54% in the last 24 hours and down -15.07% over the past month.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
See More
Previous Close:
$1.85
Open:
$1.84
24h Volume:
3.85M
Relative Volume:
5.18
Market Cap:
$206.51M
Revenue:
$21.05M
Net Income/Loss:
$-142.93M
P/E Ratio:
-1.3386
EPS:
-1.3895
Net Cash Flow:
$-184.07M
1W Performance:
+6.29%
1M Performance:
-15.07%
6M Performance:
+28.28%
1Y Performance:
+24.00%
1-Day Range:
$1.84
$1.955
1-Week Range:
$1.715
$2.02
52-Week Range:
$1.09
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.86 | 206.51M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
491.34 | 124.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
632.90 | 66.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
887.18 | 55.17B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
291.37 | 38.90B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
182.08 | 38.71B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-10-26 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
0Z2 Forecast — Price Target — Prediction for 2027 - TradingView
Alector, Inc. Actuals & Estimates (NASDAQ:ALEC) - TradingView
ALEC Forecast — Price Target — Prediction for 2027 - TradingView
A2PCBM Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to sales forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to revenue forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Price to sales forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to book forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to EBITDA forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Enterprise value to EBIT forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Alector Inc (ALEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough - Yahoo Finance
Alector Inc (ALEC) Institutional Confidence - TradingKey
Alector Inc (ALEC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alector Inc (ALEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alector Inc (ALEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alector Inc (ALEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alector Inc (ALEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alector Inc (ALEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alector Inc (ALEC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alector Shareholders Back Directors, Auditor and Executive Pay - TipRanks
[8-K] Alector, Inc. Reports Material Event - Stock Titan
Alector (ALEC) director Kristine Yaffe granted 28,700 RSUs and options - Stock Titan
Alector (ALEC) director receives 28,700 RSUs and 9,450-share option grant - Stock Titan
Alector (ALEC) board member receives new RSUs and long-dated stock options - Stock Titan
Alector (NASDAQ: ALEC) director receives new RSU and stock option awards - Stock Titan
Alector (ALEC) director awarded stock and options vesting through 2027 - Stock Titan
Equity grants lift Alector (ALEC) director Errol DeSouza’s holdings - Stock Titan
Alector (NASDAQ: ALEC) director receives RSU and stock option grants - Stock Titan
Alector Inc. (ALEC) Falls 3.72% as Shares Approach Critical Support at $1.36Option Strike Build - newsline.com
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Share Price HigherPretax Income Report - newsline.com
This Insider Has Just Sold Shares In Alector - simplywall.st
Alector Inc. (ALEC) Q1 2026 Earnings: Narrower-Than-Expected Loss Exceeds Estimates; Stock Gains Nearly 2%Pretax Income Report - newsline.com
[Form 4] Alector, Inc. Insider Trading Activity - Stock Titan
Alector (ALEC) CEO sells shares to cover RSU tax obligations - Stock Titan
Alector (ALEC) CFO Berkley sells shares to cover RSU tax obligations - Stock Titan
ALEC (NASDAQ: ALEC) Form 144 lists 3,475 restricted common shares - Stock Titan
Alector (NASDAQ: ALEC) Rule 144 notice lists RSU vesting and stock sales - Stock Titan
Alector (NASDAQ: ALEC) files to sell 132,805 RSU shares after vesting - Stock Titan
Alector halts mid-stage trial for Alzheimer’s candidate developed with GSK - MSN
ALEC Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Progress Highlights Biotech ResilienceGuidance vs Actual - newsline.com
Alector (ALEC) Edges Higher with Modest Gains, Holding Above Key SupportSkew Index - newsline.com
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Progress in Neurodegenerative Pipeline - The Legal Advocate
Alector Shares Up, Focus Turns to Pipeline After Setback - Bez Kabli
ALEC Q1 2026 Earnings: EPS Surprises with 39.95% Beat as Pipeline AdvancesInvestor Earnings Call - The Legal Advocate
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Surprises, No Revenue YetQuarterly Earnings - thelegaladvocate.com
Alector Inc. (ALEC) Holds Steady at $2.21 as Key Support and Resistance Levels Come into FocusOrder Block - The Legal Advocate
Number of shareholders of Alector, Inc. – DUS:0Z2 - TradingView
ALEC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market ResponseAnalyst Consensus Shift - Město Břeclav
Alector Inc. (ALEC) Shows Resilience: Shares Up 4.25% as Biotech Sector Watches Key LevelsCalendar Spread Trade - The Legal Advocate
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):